exhibit 10. 2 licence agreement date parties name mayne pharma ventures pty ltd, an australian company acn 168 896 357 short form name mayne pharma notice details 1538 main north road, salisbury south, sa 5106 australia facsimile : + 61 3 9614 7022 attention : general counsel name inhibitor therapeutics, inc., formerly known as hedgepath pharmaceuticals, inc., a company incorporated in delaware, successor in interest by merger to commonwealth biotechnologies, inc, a virginia corporation short form name inti notice details 900 w. platt st. # 200, tampa, fl 33606, united states facsimile : + 1 # # # - # # # - # # # # attention : ceo background a mayne pharma and inti are parties to the third amended and restated supply and license agreement dated 17 december 2018 ( the 2018 agreement ). b mayne pharma and inti are parties to a certain stipulation and agreement of compromise, settlement and release dated as of september 9, 2022 pending approval by the court of chancery of the state of delaware ( the stipulation ), pursuant to which the 2018 agreement is to be voided as of the effective date ( defined ) except as provided in the stipulation, including with respect to the licence to mayne pharma of rights arising under certain inti patents ( defined ) and inti ’ s right to a 9 % cash royalty on future net sales, if any, of the product ( defined ) in the united states and mayne pharma ’ s right to set off any royalties due to inti on future net sales of the product against usd 3, 000, 000. 00 advance paid to inti under the 2018 agreement. c in accordance with the stipulation, mayne pharma and inti have mutually agreed to the following terms and conditions to provide and govern the licence to mayne pharma of rights under of the inti patents upon the final approval of the stipulation and effective as of the effective date. if the stipulation is not approved by december 31, 2022, this licence agreement shall not become effective and the 2018 agreement shall not be voided. exhibit 10. 2 licence agreement date parties name mayne pharma ventures pty ltd, an australian company acn 168 896 357 short form name mayne pharma notice